Primary Site >> Esophagus Cancer
Gene >> IGF1
| 1. | |||||||||||
| Journal: | Cancer Res. 1991 Apr 1;51(7):1898-903. | ||||||||||
| Title: | Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. | ||||||||||
| Author: | Chen, S C|Chou, C K|Wong, F H|Chang, C M|Hu, C P | ||||||||||
| PMID: | 2004373 | ||||||||||
| 2. | |||||||||||
| Journal: | Anticancer Res. 1991 Jul-Aug;11(4):1591-5. | ||||||||||
| Title: | Effects of various growth factors on growth of a cloned human esophageal squamous cancer cell line in a protein-free medium. | ||||||||||
| Author: | Oku, K|Tanaka, A|Yamanishi, H|Nishizawa, Y|Matsumoto, K|Shiozaki, H|Mori, T | ||||||||||
| PMID: | 1746916 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Cancer. 1993 Sep 30;55(3):364-70. | ||||||||||
| Title: | Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions. | ||||||||||
| Author: | Iihara, K|Shiozaki, H|Oku, K|Tahara, H|Doki, Y|Oka, H|Kadowaki, T|Iwazawa, T|Inoue, M|Mori, T | ||||||||||
| PMID: | 8375919 | ||||||||||
| 4. | |||||||||||
| Journal: | Anesth Analg. 1996 Feb;82(2):258-63. | ||||||||||
| Title: | Postoperative alpha 2-adrenergic stimulation attenuates protein catabolism. | ||||||||||
| Author: | Mertes, N|Goeters, C|Kuhmann, M|Zander, J F | ||||||||||
| PMID: | 8561324 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Res. 1998 Nov 1;58(21):4802-4. | ||||||||||
| Title: | Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. | ||||||||||
| Author: | Zou, T|Fleisher, A S|Kong, D|Yin, J|Souza, R F|Wang, S|Smolinski, K N|Abraham, J M|Meltzer, S J | ||||||||||
| PMID: | 9809981 | ||||||||||
| 6. | |||||||||||
| Journal: | J Biomed Sci. 2002 Nov-Dec;9(6 Pt 2):665-74. | ||||||||||
| Title: | Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells. | ||||||||||
| Author: | Liu, Young-Chau|Leu, Chuen-Miin|Wong, Fen-Hwa|Fong, Wan-Shung|Chen, Shan-Chun|Chang, Chungming|Hu, Cheng-po | ||||||||||
| PMID: | 12432233 | ||||||||||
| 7. | |||||||||||
| Journal: | Anticancer Res. 2004 Sep-Oct;24(5A):3029-34. | ||||||||||
| Title: | The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer. | ||||||||||
| Author: | Sohda, Makoto|Kato, Hiroyuki|Miyazaki, Tatsuya|Nakajima, Masanobu|Fukuchi, Minoru|Manda, Ryokuhei|Fukai, Yasuyuki|Masuda, Norihiro|Kuwano, Hiroyuki | ||||||||||
| PMID: | 15517912 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Res. 2004 Nov 1;64(21):7711-23. | ||||||||||
| Title: | Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. | ||||||||||
| Author: | Takaoka, Munenori|Harada, Hideki|Andl, Claudia D|Oyama, Kenji|Naomoto, Yoshio|Dempsey, Kelly L|Klein-Szanto, Andres J|El-Deiry, Wafik S|Grimberg, Adda|Nakagawa, Hiroshi | ||||||||||
| PMID: | 15520175 | ||||||||||
| 9. | |||||||||||
| Journal: | Int J Clin Pract. 2006 Dec;60(12):1604-8. | ||||||||||
| Title: | Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer. | ||||||||||
| Author: | Yilmaz, O|Eroglu, A|Dag, E|Karaoglanoglu, N|Yilmaz, A | ||||||||||
| PMID: | 16704680 | ||||||||||
| 10. | |||||||||||
| Journal: | J Thorac Cardiovasc Surg. 2007 Mar;133(3):763-9. | ||||||||||
| Title: | Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. | ||||||||||
| Author: | Bonde, Pramod|Sui, Guoping|Dhara, Surajit|Wang, Jiaai|Broor, Apoorv|Kim, Irene F|Wiley, John E|Marti, Guy|Duncan, Mark|Jaffee, Elizabeth|Montgomery, Elizabeth|Maitra, Anirban|Harmon, John W | ||||||||||
| PMID: | 17320581 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Biol Ther. 2007 Apr;6(4):534-40. | ||||||||||
| Title: | IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. | ||||||||||
| Author: | Takaoka, Munenori|Kim, Seok-Hyun|Okawa, Takaomi|Michaylira, Carmen Z|Stairs, Douglas B|Johnstone, Cameron N|Andl, Claudia D|Rhoades, Ben|Lee, James J|Klein-Szanto, Andres J P|El-Deiry, Wafik S|Nakagawa, Hiroshi | ||||||||||
| PMID: | 17457048 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Invest. 2010 Aug;28(7):679-88. | ||||||||||
| Title: | Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis. | ||||||||||
| Author: | Che, Shao-Min|Zhang, Xiao-Zhi|Hou, Lei|Song, Tian-Bao | ||||||||||
| PMID: | 20486853 | ||||||||||
| 13. | |||||||||||
| Journal: | Apoptosis. 2011 Feb;16(2):174-83. | ||||||||||
| Title: | Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability. | ||||||||||
| Author: | Juan, Hsien-Chia|Tsai, Hsin-Ting|Chang, Po-Hao|Huang, Chi-Ying F|Hu, Cheng-Po|Wong, Fen-Hwa | ||||||||||
| PMID: | 21082354 | ||||||||||
| 14. | |||||||||||
| Journal: | Am J Gastroenterol. 2012 Feb;107(2):196-204. | ||||||||||
| Title: | IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. | ||||||||||
| Author: | Doyle, Suzanne L|Donohoe, Claire L|Finn, Stephen P|Howard, Julia M|Lithander, Fiona E|Reynolds, John V|Pidgeon, Graham P|Lysaght, Joanne | ||||||||||
| PMID: | 22146489 | ||||||||||
| 15. | |||||||||||
| Journal: | PLoS One. 2014 Mar 7;9(3):e90916. | ||||||||||
| Title: | Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer. | ||||||||||
| Author: | Ong, Jennie|Salomon, Jody|te Morsche, Rene H M|Roelofs, Hennie M J|Witteman, Ben J M|Dura, Polat|Lacko, Martin|Peters, Wilbert H M | ||||||||||
| PMID: | 24608110 | ||||||||||
| 16. | |||||||||||
| Journal: | Genet Mol Res. 2014 Jan 24;13(1):2107-19. | ||||||||||
| Title: | Genetic variations in the IGF-IGFR-IGFBP axis confer susceptibility to lung and esophageal cancer. | ||||||||||
| Author: | Huang, X P|Zhou, W H|Zhang, Y F | ||||||||||
| PMID: | 24615087 | ||||||||||
| 17. | |||||||||||
| Journal: | Sci Rep. 2014 Oct 31;4:6855. | ||||||||||
| Title: | Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma. | ||||||||||
| Author: | Zhang, Tiehong|Shen, Hongchang|Dong, Wei|Qu, Xiao|Liu, Qi|Du, Jiajun | ||||||||||
| PMID: | 25358597 | ||||||||||
| 18. | |||||||||||
| Journal: | Oncotarget. 2015 Sep 22;6(28):25897-916. | ||||||||||
| Title: | IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma. | ||||||||||
| Author: | Myers, Amy L|Lin, Lin|Nancarrow, Derek J|Wang, Zhuwen|Ferrer-Torres, Daysha|Thomas, Dafydd G|Orringer, Mark B|Lin, Jules|Reddy, Rishindra M|Beer, David G|Chang, Andrew C | ||||||||||
| PMID: | 26317790 | ||||||||||
| 19. | |||||||||||
| Journal: | Vaccines (Basel). 2015 Jul 6;3(3):519-43. | ||||||||||
| Title: | Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). | ||||||||||
| Author: | Overholser, Jay|Ambegaokar, Kristen Henkins|Eze, Siobhan M|Sanabria-Figueroa, Eduardo|Nahta, Rita|Bekaii-Saab, Tanios|Kaumaya, Pravin T P | ||||||||||
| PMID: | 26350593 | ||||||||||
| 20. | |||||||||||
| Journal: | Tumour Biol. 2016 May;37(5):6893-904. | ||||||||||
| Title: | Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. | ||||||||||
| Author: | Ye, Peng|Qu, Chang-Fa|Hu, Xue-Lin | ||||||||||
| PMID: | 26662570 | ||||||||||
| 21. | |||||||||||
| Journal: | Cancer Res Treat. 2017 Jul;49(3):778-789. | ||||||||||
| Title: | Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo. | ||||||||||
| Author: | Tang, Jian-Cai|An, Rui|Jiang, Yi-Qing|Yang, Jian | ||||||||||
| PMID: | 27857021 | ||||||||||
| 22. | |||||||||||
| Journal: | Oncol Rep. 2017 Jun;37(6):3329-3340. | ||||||||||
| Title: | A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer. | ||||||||||
| Author: | Cao, Hai-Ying|Guo, Xiao-Fang|Zhu, Xiao-Fei|Li, Sai-Sai|Zhen, Yong-Su | ||||||||||
| PMID: | 28498434 | ||||||||||
| 23. | |||||||||||
| Journal: | World J Gastroenterol. 2017 May 21;23(19):3488-3495. | ||||||||||
| Title: | Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study. | ||||||||||
| Author: | Adachi, Yasushi|Nojima, Masanori|Mori, Mitsuru|Yamashita, Kentaro|Yamano, Hiro-O|Nakase, Hiroshi|Endo, Takao|Wakai, Kenji|Sakata, Kiyomi|Tamakoshi, Akiko | ||||||||||
| PMID: | 28596684 | ||||||||||
| 24. | |||||||||||
| Journal: | Exp Cell Res. 2018 Jan 15;362(2):362-369. | ||||||||||
| Title: | Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. | ||||||||||
| Author: | Jin, Yingying|Xu, Kun|Chen, Qingjuan|Wang, Baofeng|Pan, Jiyuan|Huang, Shan|Wei, Yang|Ma, Hongbing | ||||||||||
| PMID: | 29208461 | ||||||||||